The biological interconversion of galactose and glucose takes place only by way of the Leloir pathway and requires the three enzymes galactokinase, galactose- 
The process was shown to take place through the initial phosphorylation of galactose to galactose-l-P by the action of galactokinase (galactose :ATP phosphotransferase, EC 2.7.1.6)2
(1, 2). Galactose-1-P was shown to be transformed into glucose-i-P in the presence of an enzyme and a cofactor (3) . The enzyme became known as galactose-1-P uridylyltransferase (hexose-1-P uridylyltransferase, EC 2.7.7.12), and the cofactor was identified as UDP-glucose (4, 5) . The transformation of UDP-glucose into a galactose derivative (UDP-galactose) in extracts of Streptomycesfragilis was described by Leloir in 1951 (6) . Leloir referred to this enzyme as a "Waldenase" (6) and to the system of enzymes for converting galactose into glucose-i-P as "galactowaldenase" in recognition of the apparent inversion of carbon-4 in the transformation of galactose into glucose. At the time, chemists referred to displacements at carbon that proceeded with inversion of stereochemical configuration as "Walden inversions." Mechanistic studies later showed that the process at carbon -4 of UDP-galactose is a reversible, nonstereospecific oxidation-reduction rather than a displacement. Therefore, Waldenase is now known as UDP-galactose 4-epimerase (UDP-glucose 4-epimerase, EC 5.1.3.2). The transformation of galactose into glucose-i-P by these enzymes is illustrated in Fig. 1 , which shows how UDP-glucose is cycled through UDP-galactose and thereby acts as a cofactor for the transformation of galactose-1-P into glucose-i-P.
As an energy source, galactose is the equal of glucose. One molecule of ATP is required to convert galactose into glucose-i-F, and further transformation into glucose-6-P by the action of phosphoglucomutase allows its metabolisn as an energy source through glycolysis.
The metabolism of glucose through glycolysis also requires one molecule of ATP to phosphorylate it to glucose-6-P.
The discovery and characterization of UDP-glucose in the Leloir pathway for galactose metabolism (4, 5) One might imagine that [3] the UDP-moiety is required for substrate recognition by [4] the epimerase. This is true, but it is an oversimplification, because the UDP-substituent participates directly in essential mechanistic functions and plays at least two [5] critical roles in the action of the epimerase. There is reason to believe that any enzyme catalyzing this epimerization would require either a nucleotidyl moiety or some analogous, alternative glycosyl substituent to participate in catalysis.
The functions of the nucleotide in catalysis will occupy a large part of the discussion of the epimerase in this article. The mechanism of the attachment of the uridylyl-group to the phosphate group of galactose-1-P to produce UDP-galactose will be discussed as the main function of the transferase.
The gal operon of Escherichia coli encodes the three enzymes in Fig. 1 UDP-phenol binds to a smaller domain in [7] the upper half of Fig. 2 that forms a cleft with the larger NAD domain. The uridine-5'-diphosphoryl portion of the inhibitor does not contact NAD, a fact that becomes significant in connection with chemical and spectroscopic One essential catalytic function of the UDP-group is that it serves as the binding anchor for the galactosyl, glucosyl, and 4-ketohexopyranosyl groups of the substrates and the intermediate. Binding studies of theE. coli enzyme show that most of the binding free energy between the enzyme and these molecules is directed toward binding the nucleotide portion (19, 20) . The standard free energy for binding the uridine nucleotide moieties of the substrates to the free enzyme (E'NAD +) is about -5 kcalJmol, whereas that for binding the glycosyl groups is near zero. The fluorescence lifetime of NADH in E . NADH is very short and the emission is highly polarized.
Chemical reduction of ENAD by NaB3H4 is stereospecific for the pro-S side (B side), and there is a large positive Cotton effect at 345 nm in the circular dichroism spectrum of the E. coli ENADH. The weak binding of the 4-ketohexopyranosyl moiety indicates that it may be conformationally mobile within the active site. These facts led to the proposed mechanistic scheme in Fig. 3 , in which the 4-ketohexopyranosyl group undergoes rotation about the bond linking P of UDP and the glycosyl oxygen of the 4-ketopyranosyl group. Additional rotational modes in the phosphoanhydride portion of the molecule can also participate in the positioning of the two faces of the hexopyranosyl moiety. This places the 4-keto group in positions relative to NADH that allow it to accept hydride transfer from either face to form either UDPgalactose or UDP-glucose.
Space-filling models show that this rotation can allow virtually equivalent positioning of the hydroxyl groups at glycosyl C-3 and C-4 and the hydrogen at C-4 in the substrate epimers. This recognition is illustrated in Fig. 4 which the a-and f3-glycosyl faces interact with NAD. The conformational differences leading to these relationships are described in the text.
The anchoring function of the UDP group is critically important.
There Fig. 3 and Fig. 4 because of the anchoring effect of the nucleotide portion in UDPsugars.
Another important fact about this enzyme is that uridme nucleotides induce a conformational change in both the E. coli and yeast epimerases.
The altered conformation is signified by the asterisk associated with enzyme forms in Fig. 3 to which uridine nucleotides are bound. The conformational change is a very important part of the catalytic process, and the conformationally altered form carries out hydride transfer and epimerization. A key property of this form of the enzyme is that the reactivity of E-NAD uridine nucleotide toward reducing agents is higher than that of free NAD.
This effect is observed with UMP, UDP, and UDP sugars (19, 20, 22, 25, 26) . With UMP as the activating nucleotide, enzyme-bound NAD+ is quickly reduced by glucose, arabinose, galactose, other reducing sugars, and NaBH3CN; it is reduced less rapidly by Tris buffer and glycerol; and UMP itself at high concentrations will reduce the enzyme very slowly (27) . The most reactive reducing agents will also reduce E.NAD+ very slowly in the absence of a uridine nucleotide.
Uridine nucleotides also stabilize ENADH against oxidation in the air (28) (29) (30) The structure of the enzyme shows that the UDP group of a bound nucleotide is not in direct contact with NAD (Fig. 2) , so the effects must be mediated through the protein structure by way of the conformational change from E to E*. it on C-4. This would explain the uridine nucleotide effects. The properties of the specific mutant proteins K153M and K153A support this interpretation (32) . The enzymatic activities of both mutants are about one ten-thousandth that of the wild-type enzyme, the effect being expressed mainly on kcat. UMP binds to the mutants at least as tightly as to the wild-type enzyme. NAD+ bound to these mutant forms cannot be reduced by glucose either in the presence or absence of UMP. NAD+ in both mutants can be reduced at about the same rate with NaBH3CN, but UMP has little or no effect on these reductions.
Therefore, Lys'3 is important in catalysis and essential for the UMP-dependent reduction of NAD. pulsion between the nicotinamide ring and a residue of the enzyme, Lys153, and not through enzymatic binding of the transition state. This model for activation of NAD+ implies that the positive electrostatic field is attenuated in the resting enzyme and strengthened in the enzymesubstrate complexes.
GROUND STATE DESTABILIZATION IN

ENZYMATIC
CATALYSIS
The structure of the resting enzyme will provide information on the mechanism by which the effect is switched on and off.
GALACTOSE-
1-P URIDYLYLTRANSFERASE
The essential function of the transferase in the metabolism of galactose is to incorporate the uridine nucleotide moiety into the substrate by producing UDP-galactose and glucose-i-P from UDP-glucose and galactose-i-P. Glucose-i-P enters glucose metabolism and UDP-galactose undergoes epimerization to UDP-glucose. In this way, each turnover of the transferase produces phosphorylated glucose for metabolism and introduces the catalytically essential uridylyl moiety in UDP-galactose for epimerization into UDP-glucose, which in turn provides the uridylyl moiety for another cycle of uridylyltransfer and epimerization (Fig. 1) 
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E-His' + UDP-Glc E-His UDP-GLC E-His-UMP + Glc-i-P [8] E-His-UMP + Gal-i-P E-His-UMP Gal-i-P E-His' + UDP-Gal [9] The Ping-Pong residues in turn to asparagine, followed by enzymatic analysis of extracts in which these mutant proteins had been expressed, proved that HisiM and His are the only essential histidine residues in the enzyme. To determine which of these two residues provides the catalytic nucleophile, two more specific mutants were prepared, Hi64G and H166G. These mutants lacked the f'-carbon and imidazole ring of histidine in positions 164 and i66, respectively. The absence of the histidine-imidazole rings in these mutants generated cavities that might be filled by exogenous imidazole rings. To determine whether function could be restored to the cavity in one of the mutants by added imidazole rings, the proteins were examined for activity in each the reactions of Eqs. 10 and 11.
In this experiment, UMP-5'-imidazolate served as a surrogate to the covalent UMP-imidazole moiety of the uridylyl-enzyme intermediate; that is, the catalytic imidazole ring of the active site histidine residue was incorporated within the test substrate.
The mutant H166G was found to catalyze reactions shown in both Eqs. 10 and 11 whereas the mutant H164G did not catalyze either reaction. The reaction depicted by Eq. 10 was observed in both forward and reverse directions.
The reaction in Eq. 11 was examined in only the forward direction because of the lack of a convenient assay in reverse; however, there is no reason to expect it not to be as reversible as Eq. 10. The simplest interpretation of the results is that either imidazole or the imidazole ring of uridine-5'-phosphoimidazolate can occupy the cavity created by the absence of the f-carbon and imidazole ring of His in the mutant H166G, and these exogenous imidazole rings can function in essentially the same way that His functions in the wild-type enzyme. This is illustrated in Fig. 6 . However, the essential function of His' cannot be replaced by added imidazole.
Therefore, His' provides the nucleophilic imidazole ring in the mechanism. The E. coli sequence HisProHis is conserved in a number of species of transferase. This cluster of conserved amino acids points to the possible importance of all three of them for enzymatic activity.
His
is the active site nucleophile.
The role of HisiM will be discussed further in connection with the structure of the enzyme.
There is presently no information about the role of Pro'65. The wild-type transferase will not catalyze the reactions of Eqs. 10 and ii, and the mutant H166G will not catalyze the normal transferase reaction (Eqs. 8 and 9). Therefore, H166G is more than simply an inactive mutant of the transferase.
It 
BIOCHEMICAL FUNCTION OF A COVALENT INTERMEDIATE
The double displacement, Ping-Pong mechanism for galactose-i-P uridylyltransferase has presumably arisen because of the structural similarities of glucose-i-P and galactose-i-P.
These molecules have the potential to occupy a single subsite when acting as uridylyl acceptors. In their absence, the corresponding glycosyl phosphate Figure   6 . An illustration of the mechanism of UMP-transfer catalyzed by galactose-1-P uridylyltransferase from E. coli and its mutant H166G (UDP-hexose synthase).
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THE LELOIR PATHWAY 469 Figure  7 . A ribbon diagram of the polypeptide chain in galactose-l-P uridylyltransferase fromE. coli. Shown is a ribbon diagram of one subunit in the dimeric unit of galactose-I-P uridylyltransferase from E. coli. UDP binds to the active site, and its location is illustrated in the diagram. The two metal ions Zn2+ and Fe2+ are shown in their preferential binding sites.
Neither metal ion appears to be located within the active site. At least one of the metal ions is required for enzymatic activity, and both may be required. Enzymatic activity is supported by either metal at both sites or by Co2, Mn2, or Cd2' at both sites. The metal ions most likely participate in maintaining the active conformation of the enzyme. Courtesy of Joseph E. Wedekind and Ivan Rayment.
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of UDP-glucose and UDP-galactose could also occupy the same site. The evolution of the enzyme has allowed a single subsite to serve as the binding site for both molecules.
They cannot bind simultaneously, so that some provision for maintaining chemical activation of the uridylyl-group during the changeover from glucose-i-P to galactose-1-P is required. This is accomplished through the presence of His1 in position to accept the uridylylgroup in the form of the UMP-enzyme.
The evolution of the active site and its mechanism of action appears to have been guided by the principle of economy in the evolution of binding sites. According to this principle, an enzyme evolves with the minimum number of binding sites that will allow it to function efficiently.
In the case of the uridylyltransferase, this principle leads to a single site for binding UDP-galactose and UDP-glucose. The mechanism of action of galactose-1-P uridylyltransferase may be contrasted with that of UDP-glucose pyrophosphorylase (Eq. 7). The action of UDP-glucose pyrophosphotylase does not entail a double-displacement on Pa of substrates-it proceeds with inversion of configuration-nor is there a covalent UMP-enzyme intermediate. The steady-state kinetics indicate ordered binding of substrates to form ternary complexes, and uridylyl transfer takes place directly between acceptor substrates within the ternary complexes.
The transferase and pyrophosphorylase reactions are chemically similar, however, consisting of the transfer of a uridylyl (UMP) moiety from a phophoanhydride to a phosphate acceptor. UDP-glucose is a common phosphoanhydride substrate and ut-idylyl donor for the two enzymes, and both can use glucose-i-P as an acceptor.
The differences are that UDP-glucose pyrophosphorylase uses UTP as a donor and PP1 as an acceptor in place of UDP-galactose and galactose-i-P, respectively.
The mechanism followed by galactose-1-P uridylyltransferase is evidently not practical for UDP-glucose pyrophosphorylase, presumably because of the structural differences between MgPP, and glucose-i-P. which could not easily bind to a single subsite.
Therefore, the latter enzyme evolved with separate subsites for these molecules, obviating the need for a covalent intermediate by allowing direct transfer of the uridylyl-group from MgUTP to glucose-i-P.
URIDINE NUCLEOTIDE BINDING BY THE EPIMERASE
AND TRANSFERASE Considerations of biological unity might lead to the expectation of similarities in the binding for uridine nucleotides in the epimerase and transferase.
The structures at the current state of resolution and refinement tell a different story. The binding sites for uridine nucleotides in these enzymes do not appear similar and may even be described as a study in contrasts. The binding of UDP-phenol to the epimerase active site is characterized by very strong ionic and hydrogen bonding to the diphosphate portion through Ar32, Arg291, As&79, and Asn9.
In the structure at 2.5 A resolution, the uridine nucleoside appears to interact with Phe218 through its donation of a main-chain NH-hydrogen bond to the uracil-2-oxo group and a side-chain hydrophobic contact with the uracil ring. A higher resolution structure may reveal more detail. The transferase binds UDP with extensive hydrophobic and hydrogen bonding to the uridine nucleoside and ionic binding of the diphosphate.
In the structure at 1.8 A resolution, the uridine nucleoside forms hydrophobic and hydrogen bonded contacts with LeuM, Phe75, Asn77, Asp78, Phe79, and Val61. Residues in the human enzyme corresponding to LeuM and Va161 have been implicated in human galactosemia (40) . There are also ionic and H-bonded contacts of.the diphosphate with Arg and Asn162.
From a mechanistic standpoint, differences between the binding sites are understandable on the basis of the functions of the enzymes. In the epimerase, the uridine nucleotide is a binding anchor and an inducer of a conformational change but does not itself undergo a chemical reaction.
In the transferase, the diphosphate portion of the uridine nucleotide is the substrate reaction center. These different functions may explain the need for different enzyme-nucleotide interactions.
